Psagot Value Holdings’s Charles River Laboratories CRL Stock Holding History

Psagot Value Holdings’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8	Closed	-$2K	–	526
2023 Q2	$2K	Buy	+8	New	+$1.59K	﹤0.01%	438
2022 Q1	–	Sell	-1,597	Closed	-$602K	–	354
2021 Q4	$602K	Sell	1,597 -332	-17%	-$129K	0.12%	130
2021 Q3	$796K	Sell	1,929 -886	-31%	-$368K	0.14%	127
2021 Q2	$1.04M	Buy	+2,815	New	+$940K	0.04%	153
2020 Q4	–	Sell	-3,783	Closed	-$857K	–	370
2020 Q3	$857K	Sell	3,783 -2,205	-37%	-$458K	0.02%	176
2020 Q2	$1.04M	Sell	5,988 -1,112	-16%	-$177K	0.03%	142
2020 Q1	$896K	Hold	7,100	–	–	0.04%	140
2019 Q4	$1.08M	Hold	7,100	–	–	0.04%	164
2019 Q3	$940K	Sell	7,100 -800	-10%	-$107K	0.04%	160
2019 Q2	$1.12M	Hold	7,900	–	–	0.05%	162
2019 Q1	$1.15M	Buy	7,900 +1,600	+25%	+$210K	0.05%	167
2018 Q4	$713K	Buy	+6,300	New	+$789K	0.03%	193

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Psagot Value Holdings's CRL Position: Q3 2023 in Review

Psagot Value Holdings sold out of Charles River Laboratories (CRL) in Q3 2023, closing a stake of 8 shares — an estimated $2K sold.

Psagot Value Holdings first reported a position in CRL in Q4 2018 and held it in 12 quarters. The position peaked at $1.15M in Q1 2019. 621 funds tracked by Wall St. Rank hold CRL as of Q3 2023.

Psagot Value Holdings reported no remaining Charles River Laboratories position as of Q3 2023 after selling out during the quarter.
Psagot Value Holdings sold 8 Charles River Laboratories shares in Q3 2023, an estimated $2K.
Psagot Value Holdings first reported a position in Charles River Laboratories in Q4 2018 and held it in 12 quarters.
Psagot Value Holdings's Charles River Laboratories position peaked at $1.15M in Q1 2019.
621 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2023.

Based on Psagot Value Holdings's 13F filing for Q3 2023, filed 30 Oct 2023.